HK1001996A1 - Tablet, capsule, or granule comprising desogestrel and process for making them - Google Patents

Tablet, capsule, or granule comprising desogestrel and process for making them

Info

Publication number
HK1001996A1
HK1001996A1 HK98101018A HK98101018A HK1001996A1 HK 1001996 A1 HK1001996 A1 HK 1001996A1 HK 98101018 A HK98101018 A HK 98101018A HK 98101018 A HK98101018 A HK 98101018A HK 1001996 A1 HK1001996 A1 HK 1001996A1
Authority
HK
Hong Kong
Prior art keywords
desogestrel
granule
capsule
tablet
making
Prior art date
Application number
HK98101018A
Other languages
English (en)
Inventor
Haan Pieter De
Johannes G J Egberink
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1001996(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1001996A1 publication Critical patent/HK1001996A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98101018A 1994-06-08 1998-02-11 Tablet, capsule, or granule comprising desogestrel and process for making them HK1001996A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201625 1994-06-08

Publications (1)

Publication Number Publication Date
HK1001996A1 true HK1001996A1 (en) 1998-07-24

Family

ID=8216929

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101018A HK1001996A1 (en) 1994-06-08 1998-02-11 Tablet, capsule, or granule comprising desogestrel and process for making them

Country Status (19)

Country Link
US (1) US5709881A (da)
EP (1) EP0688565B2 (da)
JP (1) JP4302783B2 (da)
KR (1) KR100380841B1 (da)
CN (1) CN1057673C (da)
AT (1) ATE254921T1 (da)
AU (1) AU697512B2 (da)
BR (1) BR9502704A (da)
CA (1) CA2150642C (da)
DE (1) DE69532176T3 (da)
DK (1) DK0688565T4 (da)
ES (1) ES2210272T5 (da)
FI (1) FI952765A (da)
HK (1) HK1001996A1 (da)
HU (1) HU218282B (da)
IL (1) IL113816A (da)
NZ (1) NZ272285A (da)
PT (1) PT688565E (da)
RU (1) RU2160107C2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60004377T2 (de) * 1999-04-06 2004-06-09 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
KR100710118B1 (ko) * 1999-07-30 2007-04-23 스미스클라인비이참피이엘시이 다성분 제약학적 제형
US7217431B2 (en) * 2001-07-06 2007-05-15 Lifecycle Pharma A/S Controlled agglomeration
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
CN105030792B (zh) * 2015-06-30 2017-08-25 上海交通大学 Desogestrel在制备抗结肠癌/ER阴性的Ah受体阳性的乳腺癌产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140915A (en) † 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3864210D1 (de) 1987-07-06 1991-09-19 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5395627A (en) † 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate

Also Published As

Publication number Publication date
ES2210272T5 (es) 2008-05-01
EP0688565B1 (en) 2003-11-26
CN1122226A (zh) 1996-05-15
FI952765A (fi) 1995-12-09
PT688565E (pt) 2004-03-31
AU697512B2 (en) 1998-10-08
BR9502704A (pt) 1996-03-05
CA2150642C (en) 2008-04-22
DE69532176T2 (de) 2004-08-12
ES2210272T3 (es) 2004-07-01
US5709881A (en) 1998-01-20
CA2150642A1 (en) 1995-12-09
EP0688565B2 (en) 2007-11-21
CN1057673C (zh) 2000-10-25
HU9501654D0 (en) 1995-07-28
DK0688565T4 (da) 2008-03-17
AU2053195A (en) 1995-12-14
IL113816A0 (en) 1995-08-31
HU218282B (en) 2000-07-28
DE69532176D1 (de) 2004-01-08
NZ272285A (en) 1996-08-27
EP0688565A1 (en) 1995-12-27
ATE254921T1 (de) 2003-12-15
KR960000231A (ko) 1996-01-25
JP4302783B2 (ja) 2009-07-29
HUT71491A (en) 1995-11-28
DK0688565T3 (da) 2004-03-29
RU2160107C2 (ru) 2000-12-10
JPH07330610A (ja) 1995-12-19
FI952765A0 (fi) 1995-06-06
DE69532176T3 (de) 2008-06-12
IL113816A (en) 1998-12-06
KR100380841B1 (ko) 2003-08-14

Similar Documents

Publication Publication Date Title
GR3032732T3 (en) Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK0489647T3 (da) N,O-sulfaterede heparosaner, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser.
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
EP0538898A3 (en) Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL85139A0 (en) Polymer complexes,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HRP930957A2 (en) Novel biologically active eburnamenine derivatives, maceutical compositions containing them and process for aring the same
ATE211745T1 (de) 10,13,15-trioxatricyclo(9.2.1.1. 9.6)- pentadecanon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA911804B (en) 1-azabicyclic compounds,processes and pharmaceutical compositions containing them
IL87563A (en) Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1001996A1 (en) Tablet, capsule, or granule comprising desogestrel and process for making them
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ZA931593B (en) 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
IL66277A (en) 3,7-dialkyl-3,7-diazabicyclo(3.3.1)nonan-9-ol derivatives,a process for the preparation thereof and pharmaceutical compositions containing them
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
ATE486083T1 (de) 11-acetyl-12,13-dioxabicyclo 8.2.1 tridecenon- derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA872443B (en) Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT45261A (en) Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them
HUT57781A (en) Process for producing cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diine derivatives and pharmaceutical compositions comprising such ring system
ATA345087A (de) Neue aminoalkanoyl-dibenzo (d,g) (1,3,6)dioxazocinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SG21094G (en) Pharmaceutical compositions containing clodronate, and process for their preparation.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090607